SAT0232 Reactivation of Immune Checkpoints by an Epitope-Specific Vaccine Reinstates Tolerogenic Pathways and Induces Clinical Amelioration in Patients With Rheumatoid Arthritis

doi 10.1136/annrheumdis-2018-eular.6126
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ Publishing Group Ltd and European League Against Rheumatism

Related search

Metabolic Checkpoints in Rheumatoid Arthritis

Frontiers in Physiology
Physiology
2020English

Patients With Rheumatoid Arthritis in Clinical Care

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2004English

Vaccine-Specific Immune Responses Correlate With Clinical Benefit

Cancer Discovery
Oncology
2012English

Assessment of Clinical and Immunological Efficacy and Safety of 23-Valent Pneumococcal Vaccine in Patients With Rheumatoid Arthritis

Pulmonologiya
PulmonaryRespiratory Medicine
2015English

AB0340 Clinical Efficacy of Statins in Patients With Rheumatoid Arthritis

2017English

Socio-Demographic Aspects and Therapeutic Pathways in Patients With Rheumatoid Arthritis in Italy

Reumatismo
Rheumatology
2011English

Efficacy and Safety of 23-Valent Pneumococcal Polysaccharide Vaccine in Patients With Rheumatoid Arthritis

The Clinician
2015English

Clinical and Laboratory Parameters Associated With Anemia in Rheumatoid Arthritis Patients

Journal of the Royal Medical Services
2018English

The Use of 23-Valent Pneumococcal Polysaccharide Vaccine in Patients With Rheumatoid Arthritis

Epidemiology and Vaccine Prevention
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy